Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease
about
Effect of allopurinol in chronic kidney disease progression and cardiovascular riskHyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data.Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002Self-rated health and adverse events in CKD.Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterizationUric acid as a mediator of diabetic nephropathy.Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate AnalysisImpact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan.Lower serum uric acid level predicts mortality in dialysis patients.Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients.New insights into uric acid effects on the progression and prognosis of chronic kidney disease.Hyperuricemia and chronic kidney disease: an enigma yet to be solved.Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease.Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.Prognostic Value of Serum Uric Acid in Patients on the Waiting List before and after Renal Transplantation.Serum uric acid levels and long-term outcomes in chronic kidney disease.Challenges of conducting a trial of uric-acid-lowering therapy in CKD.Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis.An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.Early markers of cardiovascular risk in chronic kidney disease.Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.Optical method for cardiovascular risk marker uric acid removal assessment during dialysis.Efficacy of dietary interventions in end-stage renal disease patients; a systematic review.
P2860
Q24630327-ABF019CD-5B8A-4553-8C99-683114681265Q33701688-99EAC5E2-14DE-44EE-B180-384D35A9C654Q33784030-15B2F9F1-841F-4A2D-BA13-8BAD3A8551ABQ34254522-737843C3-21ED-435C-84C6-25E75A5F7E3CQ34629749-507BFA5C-1BCA-43E7-8886-2EEBD818A994Q35046376-C82F855B-E50E-40C5-9C79-8715246A43E2Q35393446-561A5C0A-E9B3-436F-B34B-3FFA166A353EQ35711594-31522065-0E41-43F8-AA12-9B20F328B99AQ36166872-28F3296F-C00E-4E0B-9F5E-68C726D8C696Q37205566-318DEFBE-C4D3-47A8-BC23-8D9EC707CE0AQ37306126-72820F73-EDAD-4A63-B8DD-94AEA679A6BAQ37350881-636667C8-3458-49DA-8B8A-623D982D924FQ37451787-170749F3-2B25-491F-9994-128EE400BAF4Q37977142-7BF94318-5760-41DA-922F-219BCD72EB56Q38238942-DD7798B0-5AAC-4118-A6FD-DE5EA8C73687Q38849711-EA672E2D-1C55-418A-A6C4-205197E3EDC7Q39153202-5A87115E-EF9C-416E-A4C2-B03E6FE61B62Q39249344-AD78B9F8-E6C7-4254-A2B8-64C6DE7E5408Q42083079-91118877-5DBA-4B7F-8AC0-5F022B268BD2Q43905897-CC03369A-83C5-4A62-B258-079180CC1FA7Q44235739-ACCFF32A-5EDB-4926-8577-628BACB4B317Q45769948-71651615-7DBB-4D38-9FC3-19E2FC563EDFQ46650318-BC28A7AF-2A75-45D5-BEDE-CB13E2E08929Q47138528-67123AAB-9ED9-4007-AB5F-17D2497AEAB8Q48456904-E1C66E1C-DA72-440E-A256-98D2BD3A4CB0Q50044345-906061ED-AF59-4FB9-BBA1-AB5ECAD5C6BEQ51354581-A609E659-8DBD-46FC-968E-0F808F9A75A4Q54868824-CB379FE2-FEE5-4764-B744-1F5782248BD2
P2860
Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Associations of serum uric aci ...... oderate chronic kidney disease
@en
Associations of serum uric aci ...... derate chronic kidney disease.
@nl
type
label
Associations of serum uric aci ...... oderate chronic kidney disease
@en
Associations of serum uric aci ...... derate chronic kidney disease.
@nl
prefLabel
Associations of serum uric aci ...... oderate chronic kidney disease
@en
Associations of serum uric aci ...... derate chronic kidney disease.
@nl
P2860
P356
P1476
Associations of serum uric aci ...... oderate chronic kidney disease
@en
P2093
Sankar D Navaneethan
Srinivasan Beddhu
P2860
P304
P356
10.1093/NDT/GFN621
P407
P577
2008-11-25T00:00:00Z